Rambam Health Care Campus

Faculty of Medicine
Technion – Israel Institute of Technology
Department of Cardiac Surgery
Chief: Gil Bolotin, M.D. PhD
Tel: 972-4-7772631
Fax: 972-4-7772949

Bio-sketch 2022 _Bolotin
Prof. Gil Bolotin, M.D., Ph.D.
Director of Cardiac Surgery Department
Rambam Medical Center, Haifa, IsraelProf. Bolotin received his M.D. in 1993 from the Hebrew University Hadassah Medical School in Jerusalem, IsraelProf. Bolotin received his Ph.D. in 2001 from Academic Hospital Maastricht,
The Netherlands (thesis: Surgical Options to Treat Heart Failure Patients).

He performed his residency in the Department of Cardio Thoracic Surgery
at Carmel Medical Center, Haifa, Israel.

Following his graduation, Prof. Bolotin completed several fellowships:

 Mitral and Robotic Fellowship (2002-2003), Department ofSurgery, Brody School of Medicine, East Carolina University,Greenville, NC, USA Visiting Professor (2003-2004), Department of Cardiac Surgery,
University of Chicago, Chicago, Illinois, USA. Experience inadvanced cardiac surgery, heart transplants, assist devices
 Visiting Professor (2006-2007), Department of Cardiothoracic
Surgery, Academic Hospital Maastricht, Maastricht, theNetherlands. Experience in atrial fibrillation and minimallyinvasive cardiac surgery.

Rambam Health Care Campus
P.O.B. 9602, Haifa 31096, Israel
www.rambam.org.il
E-mail: g_bolotin@rambam.health.gov.il

State of Israel – Ministry of HealthTel. 972-4-7772631 Fax. 972-4-7772949

Rambam Health Care Campus

Faculty of Medicine
Technion – Israel Institute of Technology
Department of Cardiac Surgery
Chief: Gil Bolotin, M.D. PhD
Tel: 972-4-7772631
Fax: 972-4-7772949

In 2007, Prof. Bolotin was appointed Director of the Department of Cardiac
Surgery, Rambam Medical Center.
In 2015, he was appointed Clinical Associate Professor at the Ruth & Bruce
Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa,Israel.
In addition, Prof. Bolotin was the Chairman of Israel Society of Cardiothoracic
Surgery (2014-2017) and is a member of international professional
cardiothoracic societies - European Society of Cardiothoracic Surgery andWorld Society of Cardiothoracic Surgeons.
Prof. Bolotin has published over 100 publications in peer-reviewed journals
and book chapters, and has presented at numerous international
professional meetings.
Prof. Bolotin has extensive teaching experience in national and international
cardiothoracic surgery courses.
From the onset of his medical career, Prof. Bolotin was deeply interested in
medical devices from engineering design through in vitro, in vivo and clinicalstudies. His research interests have since expanded to span the entire rangeof cardiothoracic surgery, with a special interest in minimally invasive valve
surgery, transcatheter valve implantation, atrial fibrillation, robotic cardiac
surgery and other innovations in cardiac surgery.

Rambam Health Care Campus
P.O.B. 9602, Haifa 31096, Israel
www.rambam.org.il
E-mail: g_bolotin@rambam.health.gov.il

State of Israel – Ministry of HealthTel. 972-4-7772631 Fax. 972-4-7772949

Rambam Health Care Campus

Faculty of Medicine
Technion – Israel Institute of Technology
Department of Cardiac Surgery
Chief: Gil Bolotin, M.D. PhD
Tel: 972-4-7772631
Fax: 972-4-7772949

Gil Bolotin - TECHNION – RUTH & BRUCE RAPPAPORT FACULTY OF MEDICINE

1. ACADEMIC DEGREES
2001, PhD, Surgical Options to Treat Heart Failure Patients, Maastricht, The Netherlands
1993 ,MD, Hebrew University of Jerusalem - Hadassah Medical School, Jerusalem, Israel(graduated cum laude in fifth year)
1988 ,BMedSc, Ben-Gurion Medical School, Israel (graduated cum laude in first year)

2. ACADEMIC APPOINTMENTS
2015 - Present, Clinical Associate Professor, Rappaport Faculty of Medicine, Technion –Israel Institute of Technology, Haifa, Israel
2009 – 2015, Assistant Professor, Rappaport Faculty of Medicine, Technion – Israel Instituteof Technology, Haifa, Israel
2004 – 2008, Lecturer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

3. PROFESSIONAL EXPERIENCE
2007 to present, Director, Department of Cardiac Surgery, Rambam Health Care Campus,Haifa, Israel
2006 – 2007, Visiting Professor, Department of Cardiothoracic Surgery, Academic Hospital
Maastricht, Maastricht, The Netherlands
2004 – 2006, Consultant, Department of Cardiothoracic Surgery, Tel Aviv Sourasky MedicalCenter, Tel Aviv, Israel
2003 – 2004, Visiting Professor, Advanced Cardiac Surgery, Heart Transplant, Assist Devices,Atrial Fibrillation, Minimally Invasive Cardiac Surgery, Section of Cardiac and Thoracic
Surgery, University of Chicago, Chicago, Illinois, USA
2002 – 2003, Mitral and Robotic Fellowship, Department of Surgery, Brody School ofMedicine, East Carolina University, Greenville, NC, USA
2000 – 2002, Consultant, Department of Cardiothoracic Surgery, Tel Aviv Sourasky MedicalCenter, Tel Aviv, Israel
3-8/2000, Consultant, Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa,Israel
Rambam Health Care Campus
P.O.B. 9602, Haifa 31096, Israel
www.rambam.org.il
E-mail: g_bolotin@rambam.health.gov.il

State of Israel – Ministry of HealthTel. 972-4-7772631 Fax. 972-4-7772949

Rambam Health Care Campus

Faculty of Medicine
Technion – Israel Institute of Technology
Department of Cardiac Surgery
Chief: Gil Bolotin, M.D. PhD
Tel: 972-4-7772631
Fax: 972-4-7772949

1995,

Basic Science, Department of Cardiology CARIM, Academic Hospital Maastricht,Maastricht, The Netherlands.
1993 – 1999, Resident, Department of Cardiothoracic Surgery, Carmel Medical Center, Haifa,Israel
1992 – 1993, Internship, Sheba Medical Center, Tel Aviv, Israel

4. RESEARCH INTERESTS
Currently, the Department of Cardiac Surgery is engaged in both basic and clinical research.
I.

The basic science line of investigation includes the following projects:

A.

Haptoglobin genotype as a prognostic factor in patients undergoing a CABG operation.

B.

Prospective exploratory study to characterize immunological response profiles after

cardiac surgery.
C.

Development and validation of cardiovascular medical devices from the stage ofengineering design to in vitro, in vivo and clinical studies.
D.

A novel amiodarone-eluting biological glue for the prevention of postoperative atrial

fibrillation: first animal trial.
E.

The role of AP-1 transcription factor in cardiac remodoling in animal models.

II.

The clinical line of investigation includes the following projects:A.

A novel emboli protection cannula during cardiac surgery: first clinical trial.

B.

Numerical model of aortic cannula hemodynamics for evaluation of risk foratheroembolism.

Rambam Health Care Campus
P.O.B. 9602, Haifa 31096, Israel
www.rambam.org.il
E-mail: g_bolotin@rambam.health.gov.il

State of Israel – Ministry of HealthTel. 972-4-7772631 Fax. 972-4-7772949